PuSH - Publikationsserver des Helmholtz Zentrums München

Health care provider perceptions of screening for early-stage type 1 diabetes-a survey study.

Diabetes Obes. Metab., DOI: 10.1111/dom.70803 (2026)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
AIMS: To evaluate the feasibility, perceived benefits, and challenges of integrating early-stage Type 1 diabetes screening and monitoring into routine care. MATERIALS AND METHODS: Primary health care providers (HCPs; n = 683), responsible for collecting capillary blood samples and obtaining informed consent, and specialised diabetes centres (n = 17), responsible for monitoring children with early-stage Type 1 diabetes using oral glucose tolerance tests (OGTT) and HbA1c, within an early-stage Type 1 diabetes screening programme in Bavaria, Germany (Fr1da) were invited to participate in an online survey. RESULTS: Among the 194 responding primary HCPs, 66% rated overall feasibility of integrating screening in routine care as 'very good' or 'good'. More than 70% rated informing families about screening and communicating results positively, while 54% rated capillary blood sampling positively. Among the 10 responding diabetes centres, ≥ 80% rated feasibility of OGTT and HbA1c positively. Families' acceptance of glucose (on-site or at-home) and HbA1c monitoring was perceived as high. Screening was considered beneficial by 91% of primary HCPs and by all diabetes centres, emphasising reduced efforts for insulin initiation and long-term care. Reported key challenges included time and staffing constraints and inadequate reimbursement. CONCLUSIONS: Routine-care implementation of early-stage Type 1 diabetes screening is broadly supported by primary HCPs and diabetes centres and could be facilitated by refined workflows and appropriate reimbursement.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Autoimmunity ; Population Study ; Primary Care ; Type 1 Diabetes; Children; Ketoacidosis
ISSN (print) / ISBN 1462-8902
e-ISSN 1463-1326
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Förderungen Breakthrough T1D
EASD-Novo Nordisk Foundation Diabetes Prize for Excellence